|
CB-103 Clinical Trials
1 actively recruiting trial across 1 location
Boston, Massachusetts1 trial
CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Dana Farber Cancer Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.